Cambridge, MA, United States of America

Gabriel S Weatherhead

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 8.3

ph-index = 8

Forward Citations = 140(Granted Patents)


Location History:

  • Salem, MA (US) (2011 - 2013)
  • Tewksbury, MA (US) (2013 - 2016)
  • Cambridge, MA (US) (2008 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Gabriel S Weatherhead

Introduction:

Gabriel S Weatherhead, a prolific inventor based in Cambridge, MA, has made significant contributions to the field of cancer treatment through his groundbreaking innovations and patented technologies.

Latest Patents:

Weatherhead's latest patents include "Compounds and methods for inhibiting mitotic progression." This invention focuses on developing compounds that target Aurora kinase to effectively treat cancer. The pharmaceutical compositions and treatment methods outlined in these patents showcase Weatherhead's dedication to advancing cancer therapeutics.

Career Highlights:

With an impressive portfolio of 13 patents, Gabriel S Weatherhead has demonstrated a deep commitment to pushing the boundaries of medical science. His work at Millennium Pharmaceuticals Limited has been instrumental in driving forward novel approaches to cancer treatment, benefiting patients worldwide.

Collaborations:

Weatherhead has collaborated with esteemed professionals in the field, including coworkers Christopher F Claiborne and Lloyd J Payne. These partnerships have enabled him to exchange ideas, pool expertise, and bring impactful innovations to fruition.

Conclusion:

Gabriel S Weatherhead's inventions in cancer treatment underscore his talent as a visionary inventor. His relentless pursuit of novel compounds and treatment methods exemplifies the spirit of innovation that propels the medical community towards better healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…